News
Type 2 Diabetes Market Size by 2030
According to research conducted by Precedence, the global market size of type two diabetes drugs was 29.81 billion dollars in 2021 and the speculations state that by 2030 the market size will increase to 61.6 billion dollars. The type...
News
US President Biden Extends COVID-19 Public-Health Emergency
The COVID-19 public health emergency was prolonged by the Biden administration on July 15th for a further three months. The declaration was officially renewed by Xavier Becerra, Secretary of the US Department of Health and Human Services, and was...
Clinical Trials
NIH Conducts Clinical Trial of The mRNA Nipah Virus Jab
An early-stage clinical trial assessing an investigational vaccine to stave off Nipah virus infection has been started by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health. Produced by Moderna, Inc....
Drug Research
As A Side Effect, EU Lists Allergies To Novavax COVID Shots
The COVID-19 vaccine from Novavax Inc. may cause serious allergic reactions, according to the European Medicines Agency. The vaccine's product label in the United States forbids giving the shot to anyone who has had a history of acute toxicity to...
Drug Research
No Rush In Indian Generic Drug Firms To Offer COVID Products
Indian generic drugmakers are delaying more investments in COVID-related drugs after making gains in the last two years, according to certain pharmaceutical industry insiders.
BDR Pharmaceuticals' managing director, Dharmesh Shah, stated that when COVID-19 cases start to decline, his company is...
Drug Research
Genomic Studies Utilize Scale As Clinical Utility Catches Up
An innovative system for monitoring chromosomal fragility and copy number alterations in particularly lethal tumours was described earlier this July by researchers from Cambridge University and the National Cancer Research Center in Madrid. Researchers believe this is the first time...
Drug Research
Novavax COVID-19 Vaccine Is Fourth US Option Now Available
As infections in the U.S. continue to be at high levels, the Food and Drug Administration on 13th July approved a fourth vaccination for COVID-19 prevention, authorising Novavax's coronavirus jab for emergency use in adults. The Maryland-based drugmaker's early results on...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read